Supercede Therapeutics
CA - BelmontBiotechnology
Focus: Supercede Therapeutics is an early-stage biotech founded in 2023 focused on bioinformatic drug discovery, based in Belmont, CA. The company is pre-revenue with minimal public pipeline visibility.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Open Jobs
2+2 this month
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Should You Work at Supercede Therapeutics?
AI assessmentHigh-risk, high-upside early-stage bet suitable only for career-stage professionals comfortable with uncertainty and motivated by equity and foundational impact.
Why Work Here
- Ground-floor opportunity at a newly formed company with emerging focus on computational drug discovery—rare chance to shape company culture and scientific direction from inception.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Supercede Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.